Literature DB >> 25849892

Diverse effects of LPA4, LPA5 and LPA6 on the activation of tumor progression in pancreatic cancer cells.

Shuhei Ishii1, Miku Hirane1, Kaori Fukushima1, Ayaka Tomimatsu1, Nobuyuki Fukushima2, Toshifumi Tsujiuchi3.   

Abstract

Lysophosphatidic acid (LPA) is an extracellular biological lipid which interacts with G protein-coupled LPA receptors (LPA1 to LPA6). LPA signaling via LPA receptors mediates several cellular responses. In the present study, to assess the roles of LPA4, LPA5 and LPA6 in cellular functions of pancreatic cancer cells, we generated LPA receptor knockdown cells from PANC-1 cells (PANC-sh4, PANC-sh5 and PANC-sh6 cells, respectively). In cell motility assay, PANC-sh4 and PANC-sh5 cells enhanced the cell motile activities, compared with control cells. In contrast, the cell motile activity of PANC-sh6 cells was suppressed. The invasive activities of PANC-sh4 and PANC-sh5 cells were markedly stimulated, while PANC-sh6 cells showed the low invasive activity. In colony assay, PANC-sh4 and PANC-sh5 cells formed the large sized colonies, but not PANC-sh6 cells. When endothelial cells were incubated with supernatants from PANC-sh4 and PANC-sh5 cells, the cell motility and tube formation of endothelial cells were significantly induced, but not PANC-sh6 cells. These results suggest that the diverse roles of LPA4, LPA5 and LPA6 are involved in the activation of tumor progression in pancreatic cancer cells.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  LPA; LPA receptor; Pancreatic cancer cells; Tumor progression

Mesh:

Substances:

Year:  2015        PMID: 25849892     DOI: 10.1016/j.bbrc.2015.03.169

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  Lysophosphatidic Acid Receptor 6 (LPAR6) Expression and Prospective Signaling Pathway Analysis in Breast Cancer.

Authors:  Kai Tao; Shipeng Guo; Rui Chen; Chengcheng Yang; Lei Jian; Haochen Yu; Shengchun Liu
Journal:  Mol Diagn Ther       Date:  2019-02       Impact factor: 4.074

Review 2.  GPCRs in pancreatic adenocarcinoma: Contributors to tumour biology and novel therapeutic targets.

Authors:  Krishna Sriram; Cristina Salmerón; Shu Z Wiley; Paul A Insel
Journal:  Br J Pharmacol       Date:  2020-04-12       Impact factor: 8.739

Review 3.  Lipids in the tumor microenvironment: From cancer progression to treatment.

Authors:  Kevin C Corn; McKenzie A Windham; Marjan Rafat
Journal:  Prog Lipid Res       Date:  2020-08-11       Impact factor: 16.195

Review 4.  Regulation of tumor cell - Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis.

Authors:  Gabor J Tigyi; Junming Yue; Derek D Norman; Erzsebet Szabo; Andrea Balogh; Louisa Balazs; Guannan Zhao; Sue Chin Lee
Journal:  Adv Biol Regul       Date:  2018-09-16

5.  Higher LPA2 and LPA6 mRNA Levels in Hepatocellular Carcinoma Are Associated with Poorer Differentiation, Microvascular Invasion and Earlier Recurrence with Higher Serum Autotaxin Levels.

Authors:  Kenichiro Enooku; Baasanjav Uranbileg; Hitoshi Ikeda; Makoto Kurano; Masaya Sato; Hiroki Kudo; Harufumi Maki; Kazuhiko Koike; Kiyoshi Hasegawa; Norihiro Kokudo; Yutaka Yatomi
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

Review 6.  Lysophospholipid Signaling in the Epithelial Ovarian Cancer Tumor Microenvironment.

Authors:  Yan Xu
Journal:  Cancers (Basel)       Date:  2018-07-09       Impact factor: 6.639

Review 7.  Lipid Phosphate Phosphatases and Cancer.

Authors:  Xiaoyun Tang; David N Brindley
Journal:  Biomolecules       Date:  2020-09-02

Review 8.  Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies.

Authors:  Luiz Henrique Medeiros Geraldo; Tânia Cristina Leite de Sampaio Spohr; Rackele Ferreira do Amaral; Anna Carolina Carvalho da Fonseca; Celina Garcia; Fabio de Almeida Mendes; Catarina Freitas; Marcos Fabio dosSantos; Flavia Regina Souza Lima
Journal:  Signal Transduct Target Ther       Date:  2021-02-01

Review 9.  Targeting Lysophosphatidic Acid in Cancer: The Issues in Moving from Bench to Bedside.

Authors:  Yan Xu
Journal:  Cancers (Basel)       Date:  2019-10-10       Impact factor: 6.639

10.  Lysophosphatidic Acid Receptor 5 (LPAR5) Plays a Significance Role in Papillary Thyroid Cancer via Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin (mTOR) Pathway.

Authors:  Cheng-Yong Wu; Chen Zheng; Er-Jie Xia; Rui-Da Quan; Jing Hu; Xiao-Hua Zhang; Ru-Tian Hao
Journal:  Med Sci Monit       Date:  2020-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.